Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Mammalian Genome

• Publication date

  2015-02-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00335-015-9560-4PMID 25721416PMCID PMC4629800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Responsiveness of cardiometabolic-related microbiota to diet is influenced by host genetics

  2014cited by this paper
• Gastrointestinal pathology in juvenile and adult CFTR-knockout ferrets.

  2014cited by this paper
• Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with cystic fibrosis.

  2014cited by this paper
• Lung phenotype of juvenile and adult cystic fibrosis transmembrane conductance regulator-knockout ferrets.

  2014cited by this paper
• 50 Modification of the salivary secretion assay in F508del mice – Salivary chloride quantification and its correlation to the human sweat test

  2013cited by this paper
• Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota

  2013cited by this paper
• Laxative treatment with polyethylene glycol decreases microbial primary bile salt dehydroxylation and lipid metabolism in the intestine of rats.

  2013cited by this paper
• Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice

  2013cited by this paper
• A functional CFTR assay using primary cystic fibrosis intestinal organoids

  2013cited by this paper
• Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota.

  2013cited by this paper
• Modification of the salivary secretion assay in F508del mice--the murine equivalent of the human sweat test.

  2013cited by this paper
• Correction of Chloride Transport and Mislocalization of CFTR Protein by Vardenafil in the Gastrointestinal Tract of Cystic Fibrosis Mice

  2013cited by this paper
• Nebulized Hyaluronan Ameliorates lung inflammation in cystic fibrosis mice

  2013cited by this paper
• Decade-long bacterial community dynamics in cystic fibrosis airways

  2012cited by this paper
• Prevalence of Streptococci and Increased Polymicrobial Diversity Associated with Cystic Fibrosis Patient Stability

  2012cited by this paper
• CFTR, mucins, and mucus obstruction in cystic fibrosis.

  2012cited by this paper
• Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota

  2012cited by this paper
• Structure, Function and Diversity of the Healthy Human Microbiome

  2012cited by this paper
• Airway hyperresponsiveness in FVB/N delta F508 cystic fibrosis transmembrane conductance regulator mice.

  2012cited by this paper
• Functional Cftr in crypt epithelium of organotypic enteroid cultures from murine small intestine.

  2012cited by this paper
• Serial Analysis of the Gut and Respiratory Microbiome in Cystic Fibrosis in Infancy: Interaction between Intestinal and Respiratory Tracts and Impact of Nutritional Exposures

  2012cited by this paper
• Early life antibiotic‐driven changes in microbiota enhance susceptibility to allergic asthma

  2012cited by this paper
• Host genetic and environmental effects on mouse intestinal microbiota

  2012cited by this paper
• Ileal smooth muscle dysfunction and remodeling in cystic fibrosis.

  2012cited by this paper
• Strain-Dependent Airway Hyperresponsiveness and a Chromosome 7 Locus of Elevated Lymphocyte Numbers in Cystic Fibrosis Transmembrane Conductance Regulator-Deficient Mice

  2012cited by this paper
• Gut dysbiosis in cystic fibrosis.

  2012cited by this paper
• Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine

  2012cited by this paper
• MicroRNA profiling of cystic fibrosis intestinal disease in mice.

  2011cited by this paper
• Intestinal Obstruction Syndromes in Cystic Fibrosis: Meconium Ileus, Distal Intestinal Obstruction Syndrome, and Constipation

  2011cited by this paper
• UCHIME improves sensitivity and speed of chimera detection

  2011cited by this paper
• Cross-Sectional and Longitudinal Comparisons of the Predominant Fecal Microbiota Compositions of a Group of Pediatric Patients with Cystic Fibrosis and Their Healthy Siblings

  2011cited by this paper
• Mouse models of cystic fibrosis: phenotypic analysis and research applications.

  2011cited by this paper
• IGF Binding Protein-3 Treatment Alters Intestinal Cell Proliferation But Not Body Weight of Adult Cystic Fibrosis Transmembrane Conductance Regulator Deficient Mice

  2011cited by this paper
• Nod2 is essential for temporal development of intestinal microbial communities

  2011cited by this paper
• Reducing the Effects of PCR Amplification and Sequencing Artifacts on 16S rRNA-Based Studies

  2011cited by this paper
• Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine

  2010cited by this paper
• Small intestinal bacterial overgrowth: histopathologic features and clinical correlates in an underrecognized entity.

  2010cited by this paper
• Osteopenia in Cftr-deltaF508 mice.

  2010cited by this paper
• Biomechanical remodelling of obstructed guinea pig jejunum.

  2010cited by this paper
• Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice.

  2010cited by this paper
• Accurate determination of microbial diversity from 454 pyrosequencing data

  2009cited by this paper
• Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples

  2009cited by this paper
• Bacterial Community Variation in Human Body Habitats Across Space and Time

  2009cited by this paper
• Induction of intestinal Th17 cells by segmented filamentous bacteria.

  2009cited by this paper
• Cystic fibrosis

  2009cited by this paper
• Small intestine bacterial overgrowth is frequent in cystic fibrosis: combined hydrogen and methane measurements are required for its detection.

  2009cited by this paper
• Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities

  2009cited by this paper
• Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice.

  2009cited by this paper
• Polymicrobial Nature of Chronic Diabetic Foot Ulcer Biofilm Infections Determined Using Bacterial Tag Encoded FLX Amplicon Pyrosequencing (bTEFAP)

  2008cited by this paper
• Intestinal phenotype of variable-weight cystic fibrosis knockout mice.

  2007cited by this paper
• Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy

  2007cited by this paper
• Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine.

  2007cited by this paper
• SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB

  2007cited by this paper
• Risk Factors for Small Bowel Bacterial Overgrowth in Cystic Fibrosis

  2007cited by this paper
• Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine

  2007cited by this paper
• Increased levels of mucins in the cystic fibrosis mouse small intestine, and modulator effects of the Muc1 mucin expression.

  2006cited by this paper
• Strain-dependent pulmonary gene expression profiles of a cystic fibrosis mouse model.

  2006cited by this paper
• Relaxed Neighbor Joining: A Fast Distance-Based Phylogenetic Tree Construction Method

  2006cited by this paper
• Interactions Between Commensal Bacteria and Gut Sensorimotor Function in Health and Disease

  2005cited by this paper
• Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model.

  2004cited by this paper
• Improved extraction of PCR-quality community DNA from digesta and fecal samples.

  2004cited by this paper
• Bacterial Overgrowth in the Cystic Fibrosis Transmembrane Conductance Regulator Null Mouse Small Intestine

  2004cited by this paper
• Abnormal Paneth cell granule dissolution and compromised resistance to bacterial colonization in the intestine of CF mice.

  2004cited by this paper
• Quantification of Intestinal Bacterial Populations by Real-Time PCR with a Universal Primer Set and Minor Groove Binder Probes: a Global Approach to the Enteric Flora

  2004cited by this paper
• Na-H Exchange-dependent Increase in Intracellular pH Times G2/M Entry and Transition*

  2003cited by this paper
• Cystic fibrosis

  2003cited by this paper
• Mapping of genetic factors influencing the weight of cystic fibrosis knockout mice

  2002cited by this paper
• Proliferation, not apoptosis, alters epithelial cell migration in small intestine of CFTR null mice.

  2001cited by this paper
• Changes in the exocrine pancreas secondary to altered small intestinal function in the CF mouse.

  2001cited by this paper
• A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.

  1996cited by this paper
• Increased survival of CFTR knockout mice with an oral osmotic laxative.

  1996cited by this paper
• Phenotypic Abnormalities in Long-Term Surviving Cystic Fibrosis Mice

  1996cited by this paper
• A mouse model for the cystic fibrosis delta F508 mutation.

  1995cited by this paper
• An Animal Model for Cystic Fibrosis Made by Gene Targeting

  1992cited by this paper
• Inflammation causes hyperplasia and hypertrophy in smooth muscle of rat small intestine.

  1992cited by this paper

• Intestinal adaptations increase basolateral intestinal glucose uptake and glycolysis in a mouse model of Cystic Fibrosis.

  2025cites this paper
• Increased Activity of Epithelial Cdc42 Rho GTPase and Tight Junction Permeability in the Cftr Knockout Intestine.

  2024cites this paper
• Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D trial) in adults with cystic fibrosis

  2024cites this paper
• Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 × 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D Trial) in adults with cystic fibrosis

  2024cites this paper
• Fecal Dysbiosis and Inflammation in Intestinal-Specific Cftr Knockout Mice on Regimens Preventing Intestinal Obstruction.

  2023cites this paper
• Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome

  2023cites this paper
• Fecal Dysbiosis and Inflammation in Intestinal-Specific Cftr Knockout Mice on Regimens Preventing Intestinal Obstruction

  2023influential citation
• Microbiome in Cystic Fibrosis

  2022cites this paper
• CFTR and Gastrointestinal Cancers: An Update

  2022cites this paper
• Alterations of mucosa-attached microbiome and epithelial cell numbers in the cystic fibrosis small intestine with implications for intestinal disease

  2022cites this paper
• The Gut-Lung Axis in Cystic Fibrosis

  2021cites this paper
• Goblet Cell Hyperplasia is not Epithelial-Autonomous in the Cftr Knockout Intestine.

  2021cites this paper
• Lung and Gut Microbiota Changes Associated with Pseudomonas aeruginosa Infection in Mouse Models of Cystic Fibrosis

  2021cites this paper
• Rodent models of cholestatic liver disease: A practical guide for translational research

  2021cites this paper
• Intestinal Dysbiosis in Young Cystic Fibrosis Rabbits

  2021cites this paper
• Exploring the impact of intestinal ion transport on the gut microbiota

  2020cites this paper
• The Microbiome in Cystic Fibrosis Pulmonary Disease

  2020cites this paper
• Disrupted local innervation results in less VIP expression in CF mice tissues.

  2020cites this paper
• Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota

  2019cites this paper
• ClC transporter activity modulates histidine catabolism in Lactobacillus reuteri by altering intracellular pH and membrane potential

  2019cites this paper
• Epithelial-microbial diplomacy: escalating border tensions drive inflammation in inflammatory bowel disease

  2019cites this paper
• SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion

  2018cites this paper
• Role of vitamin D on gut microbiota in cystic fibrosis.

  2018cites this paper
• Alginate Oligomers and Their Use as Active Pharmaceutical Drugs

  2018cites this paper
• Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients

  2017cites this paper
• Stem cell-derived organoids to model gastrointestinal facets of cystic fibrosis

  2017cites this paper
• Chapter 7: Lung Microbiota and its Impact on the Mucosal Immune Phenotype

  2017cites this paper
• Lung Microbiota and Its Impact on the Mucosal Immune Phenotype

  2017cites this paper
• The CF gastrointestinal microbiome: Structure and clinical impact

  2016cites this paper
• Decreased Expression of Enterocyte Nutrient Assimilation Genes and Proteins in the Small Intestine of Cystic Fibrosis Mouse.

  2016cites this paper
• Streptomycin treatment alters the intestinal microbiome, pulmonary T cell profile and airway hyperresponsiveness in a cystic fibrosis mouse model

  2016cites this paper
• A novel guluronate oligomer improves intestinal transit and survival in cystic fibrosis mice.

  2016cites this paper
• Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health.

  2016cites this paper